No Data
No Data
The Nasdaq 100 is about to adjust, and these 11 companies may see a 50% increase in upside potential.
As the annual adjustment of the NASDAQ 100 Index approaches, a group of potential stocks is preparing to make their debut. This adjustment not only brings prestige to these companies but may also trigger a large-scale inflow of capital, further driving up stock prices.
DexCom's (NASDAQ:DXCM) Returns On Capital Are Heading Higher
TNDM Stock to Gain From T:slim X2 With Dexcom G7 Launch in Canada
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
Why DexCom, Inc. (NASDAQ:DXCM) Looks Like A Quality Company
Nephron Research Adjusts Price Target on DexCom to $125 From $145